Lexeo Therapeutics (LXEO) Reiterated at Overweight by Cantor Fitzgerald Jan 13, 2026 07:08AM
Lexeo Therapeutics (LXEO) PT Lowered to $10 at H.C. Wainwright Jan 13, 2026 06:40AM
Oppenheimer on Lexeo Therapeutics (LXEO): 'We regard the selloff as having made the shares more attractive' Jan 13, 2026 06:23AM
Lexeo reports interim data for heart condition gene therapy Jan 12, 2026 07:01AM
Lexeo partners with Johnson & Johnson on cardiac gene therapy delivery Jan 8, 2026 07:08AM


Dec 17, 2025 04:05PM Raymond James Starts Lexeo Therapeutics (LXEO) at Strong Buy, PT $25
Dec 10, 2025 07:31AM Lexeo Therapeutics' (LXEO) PKP2-ACM Program Under the Radar - Cantor Fitzgerald
Dec 10, 2025 06:38AM Oppenheimer Reiterates Outperform Rating on Lexeo Therapeutics (LXEO)
Dec 1, 2025 06:58AM Lexeo Therapeutics (LXEO) PKP2-ACM Data Can Put Stock on Radars - Cantor Fitzgerald
Nov 20, 2025 06:06AM Cantor Fitzgerald Starts Lexeo Therapeutics (LXEO) at Overweight
Nov 5, 2025 04:22PM Lexeo Therapeutics, Inc. (LXEO) Tops Q3 EPS by 51c
Nov 5, 2025 09:13AM Lexeo Therapeutics (LXEO) files for 1.25M share offering by selling stockholders
Oct 21, 2025 06:43AM Lexeo Therapeutics (LXEO) PT Lowered to $13 at H.C. Wainwright
Oct 17, 2025 01:07PM Lexeo Therapeutics (LXEO) PT Lowered to $18 at Stifel
Oct 8, 2025 06:46AM Lexeo Therapeutics (LXEO) PT Raised to $15 at H.C. Wainwright
Oct 7, 2025 06:01AM Lexeo advances toward accelerated approval for gene therapy
Aug 15, 2025 06:52AM Lexeo Therapeutics (LXEO) PT Lowered to $9 at H.C. Wainwright
Aug 14, 2025 04:19PM Lexeo Therapeutics, Inc. (LXEO) Tops Q2 EPS by 31c
Aug 14, 2025 10:41AM Lexeo Therapeutics (LXEO) PT Lowered to $9 at Leerink Partners
Jul 31, 2025 06:22AM Oppenheimer Starts Lexeo Therapeutics (LXEO) at Outperform
Jul 7, 2025 07:37AM Stifel Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Jul 7, 2025 07:01AM Lexeo gets FDA breakthrough therapy designation for heart condition drug
Jun 26, 2025 04:58PM Lexeo Therapeutics (LXEO) Files for 41.63M Share Offering by Selling Stockholders
Jun 5, 2025 12:44PM FDA Cell and Gene Therapy Roundtable 'bullish for the space' - Stifel
May 27, 2025 01:08PM Lexeo Therapeutics (LXEO) PT Lowered to $10 at Leerink Partners
May 27, 2025 07:32AM Lexeo Therapeutics (LXEO) Announces $80M Equity Financing
May 16, 2025 06:44AM Lexeo Therapeutics (LXEO) PT Lowered to $15 at H.C. Wainwright
May 13, 2025 04:33PM Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c
May 12, 2025 07:00AM Lexeo Therapeutics, Inc. (LXEO) Misses Q1 EPS by 10c
Apr 8, 2025 06:46AM H.C. Wainwright Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Apr 7, 2025 06:22AM Lexeo Therapeutics (LXEO) Announces Positive Interim Phase 1/2 Data for LX2006
Mar 26, 2025 06:50AM H.C. Wainwright Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Mar 24, 2025 10:20AM Lexeo Therapeutics (LXEO) PT Lowered to $18 at Leerink Partners, 'we continue to see favorable risk/reward into 2H25'
Mar 24, 2025 07:02AM Lexeo Therapeutics, Inc. (LXEO) Misses Q4 EPS by 6c
Dec 19, 2024 07:01AM Lexeo Therapeutics (LXEO) Appoints Kyle Rasbach as CFO
Dec 13, 2024 08:21AM Lexeo Therapeutics (LXEO) Files $300M Mixed Shelf
Nov 14, 2024 06:59AM Lexeo Therapeutics (LXEO) PT Raised to $23 at H.C. Wainwright
Nov 13, 2024 04:33PM Lexeo Therapeutics, Inc. (LXEO) Misses Q3 EPS by 17c
Oct 30, 2024 06:16AM Lexeo Therapeutics (LXEO) Reports Positive Interim Data for LX1001
Aug 16, 2024 05:30AM Stifel Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Aug 13, 2024 06:42AM Lexeo Therapeutics (LXEO) PT Lowered to $21 at H.C. Wainwright
Jul 16, 2024 10:53AM H.C. Wainwright Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Jul 15, 2024 07:39AM Stifel on Lexeo Therapeutics (LXEO): 'FA-CM Data Look Promising Though Handful of Questions for 8AM Call'
Jul 15, 2024 06:02AM Lexeo Therapeutics (LXEO) Reports Positive Interim Phase 1/2 Clinical Data of LX2006
Jun 12, 2024 04:07PM Baird Starts Lexeo Therapeutics (LXEO) at Outperform